Repros Therapeutics (RPRX) Files 2.15M Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Join SI Premium – FREE
Repros Therapeutics Inc. (Nasdaq: RPRX) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 2,145,636 shares of its Common Stock on behalf of holders.
Repros will not receive proceeds from the secondary offering.
Repros will not receive proceeds from the secondary offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- EShallGo closes $1.75M registered direct offering at $1 per share
- WhiteFiber closes $310M convertible notes offering at 5% due 2032
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
